MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma
- 1 May 2013
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 331 (2) , 230-238
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction ChemoradiotherapyThe Annals of Thoracic Surgery, 2012
- Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic CarcinomaMolecular Pharmacology, 2011
- MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor ProgressionInternational Journal of Immunopathology and Pharmacology, 2010
- miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck CarcinomaCancer Research, 2010
- MicroRNAs: Novel regulators in the hallmarks of human cancerCancer Letters, 2009
- Progressive Tumor Formation in Mice with Conditional Deletion of TGF-β Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt PathwayCancer Research, 2009
- MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancerBreast Cancer Research, 2009
- Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal CancerCancer Research, 2008
- TGFβ in CancerCell, 2008
- Maximizing mouse cancer modelsNature Reviews Cancer, 2007